Title : Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment.

Pub. Date : 2020 Nov 15

PMID : 32958546






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment. Glutamic Acid isocitrate dehydrogenase (NADP(+)) 1 Homo sapiens
2 SIGNIFICANCE: These findings show that glutamate can be used as a noninvasive, imageable metabolic marker for early assessment of tumor response to temozolomide, with the potential to improve treatment strategies for mutant IDH1 patients. Glutamic Acid isocitrate dehydrogenase (NADP(+)) 1 Homo sapiens